Diomics Corporation
William Zimlich has extensive experience in leadership positions within the medical technology sector, including a current role on the Scientific Advisory Board at Diomics Corporation since July 2020. Previously, Zimlich served as Chief Executive Officer at Monitored Therapeutics, Inc. from July 2014 to July 2018, where the focus was on enhancing patient adherence to medication and diagnostics. Prior to this, Zimlich was CEO of Activaero America, Inc. until its acquisition by Vectura PLC, and has held various roles in product development and engineering, including Vice President positions at Battelle Pulmonary Therapeutics and Battelle. Zimlich's early career includes managerial roles at Medex, AMS Plastics, Stratagene, and Cambridge Automation. Educational qualifications include an MBA from the University of Detroit Mercy and a BSME in mechanical engineering/biomechanics from The Ohio State University.
This person is not in any teams
This person is not in any offices
Diomics Corporation
Diomics Corporation, based in San Diego, creates highly efficient hydrophilic materials, based on patented Diomat™ technology, that improve the speed, sensitivity and accuracy in the capture and detection of nucleic acids, proteins and similar compounds.